Granules India Limited Logo

Granules India Limited

GRANULES.NS

(2.5)
Stock Price

562,15 INR

0% ROA

15.89% ROE

27.41x PER

Market Cap.

134.878.348.500,00 INR

0% DER

0.27% Yield

10.47% NPM

Granules India Limited Stock Analysis

Granules India Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Granules India Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (16.08%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 DER

The stock has a minimal amount of debt (40%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

3 Assets Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

4 Dividend

Investors can take comfort in the company's unwavering commitment to dividends, as it has consistently distributed payouts over the past five years, ensuring a reliable income stream.

5 ROA

The stock's ROA (9.47%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

6 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (3.885), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

7 PBV

The stock's elevated P/BV ratio (3.18x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

8 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

9 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

10 Graham Number

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

11 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

Granules India Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Granules India Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Granules India Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Granules India Limited Revenue
Year Revenue Growth
2006 1.881.355.960
2007 2.564.543.052 26.64%
2008 0 0%
2009 4.610.892.654 100%
2010 4.751.797.565 2.97%
2011 6.539.659.000 27.34%
2012 7.643.731.000 14.44%
2013 10.958.648.000 30.25%
2014 12.929.224.000 15.24%
2015 14.295.327.000 9.56%
2016 14.096.690.000 -1.41%
2017 16.345.219.000 13.76%
2018 22.343.587.000 26.85%
2019 25.452.359.000 12.21%
2020 31.960.346.000 20.36%
2021 37.271.723.000 14.25%
2022 45.119.170.000 17.39%
2023 47.579.520.000 5.17%
2023 45.063.670.000 -5.58%
2024 47.194.600.000 4.52%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Granules India Limited Research and Development Expenses
Year Research and Development Expenses Growth
2006 0
2007 0 0%
2008 0 0%
2009 36.706.847 100%
2010 34.091.240 -7.67%
2011 0 0%
2012 54.608.000 100%
2013 67.922.000 19.6%
2014 96.096.000 29.32%
2015 165.397.000 41.9%
2016 256.753.000 35.58%
2017 524.780.000 51.07%
2018 725.141.000 27.63%
2019 789.091.000 8.1%
2020 1.001.574.000 21.21%
2021 1.429.606.000 29.94%
2022 1.163.800.000 -22.84%
2023 0 0%
2023 1.985.600.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Granules India Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2006 106.199.983
2007 155.506.827 31.71%
2008 0 0%
2009 239.464.042 100%
2010 254.594.253 5.94%
2011 0 0%
2012 83.797.000 100%
2013 103.917.000 19.36%
2014 182.439.000 43.04%
2015 159.981.000 -14.04%
2016 167.357.000 4.41%
2017 265.027.000 36.85%
2018 286.152.000 7.38%
2019 339.805.000 15.79%
2020 375.620.000 9.53%
2021 514.428.000 26.98%
2022 738.750.000 30.37%
2023 0 0%
2023 851.260.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Granules India Limited EBITDA
Year EBITDA Growth
2006 313.346.360
2007 372.886.479 15.97%
2008 0 0%
2009 737.196.638 100%
2010 576.569.483 -27.86%
2011 804.911.000 28.37%
2012 839.926.000 4.17%
2013 1.558.051.000 46.09%
2014 2.087.432.000 25.36%
2015 2.819.418.000 25.96%
2016 3.029.613.000 6.94%
2017 2.993.171.000 -1.22%
2018 4.541.734.000 34.1%
2019 6.182.633.000 26.54%
2020 8.790.286.000 29.67%
2021 7.332.538.000 -19.88%
2022 9.276.000.000 20.95%
2023 8.580.160.000 -8.11%
2023 8.559.799.999 -0.24%
2024 10.370.760.000 17.46%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Granules India Limited Gross Profit
Year Gross Profit Growth
2006 400.507.263
2007 520.141.070 23%
2008 0 0%
2009 896.815.850 100%
2010 856.837.279 -4.67%
2011 2.396.006.000 64.24%
2012 2.903.011.000 17.46%
2013 3.835.924.000 24.32%
2014 4.572.381.000 16.11%
2015 5.688.204.000 19.62%
2016 7.071.120.000 19.56%
2017 7.093.207.000 0.31%
2018 9.490.680.000 25.26%
2019 12.296.755.000 22.82%
2020 17.410.300.000 29.37%
2021 17.682.683.000 1.54%
2022 22.046.290.000 19.79%
2023 24.574.880.000 10.29%
2023 16.799.280.000 -46.29%
2024 19.157.800.000 12.31%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Granules India Limited Net Profit
Year Net Profit Growth
2006 75.962.851
2007 90.043.635 15.64%
2008 0 0%
2009 303.719.621 100%
2010 208.958.382 -45.35%
2011 299.528.000 30.24%
2012 325.673.000 8.03%
2013 752.313.000 56.71%
2014 909.078.000 17.24%
2015 1.184.676.000 23.26%
2016 1.645.191.000 27.99%
2017 1.325.912.000 -24.08%
2018 2.364.085.000 43.91%
2019 3.353.983.000 29.51%
2020 5.494.590.000 38.96%
2021 4.127.610.000 -33.12%
2022 5.165.970.000 20.1%
2023 4.084.640.000 -26.47%
2023 4.053.100.000 -0.78%
2024 5.385.920.000 24.75%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Granules India Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2006 1
2007 0 0%
2008 0 0%
2009 2 100%
2010 1 0%
2011 1 0%
2012 2 0%
2013 4 66.67%
2014 4 25%
2015 6 20%
2016 8 28.57%
2017 5 -40%
2018 9 44.44%
2019 13 30.77%
2020 22 40.91%
2021 17 -37.5%
2022 21 23.81%
2023 17 -31.25%
2023 17 0%
2024 22 27.27%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Granules India Limited Free Cashflow
Year Free Cashflow Growth
2006 781.076.756
2007 716.284.278 -9.05%
2009 469.356.421 -52.61%
2010 235.995.300 -98.88%
2011 -266.342.000 188.61%
2012 -242.582.000 -9.79%
2013 -1.587.850.000 84.72%
2014 -27.515.000 -5670.85%
2015 91.190.000 130.17%
2016 -1.162.916.000 107.84%
2017 -4.470.870.000 73.99%
2018 -171.593.000 -2505.51%
2019 2.917.094.000 105.88%
2020 1.611.362.000 -81.03%
2021 -656.528.000 345.44%
2022 4.518.850.000 114.53%
2023 0 0%
2023 -410.580.000 100%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Granules India Limited Operating Cashflow
Year Operating Cashflow Growth
2006 36.753.575
2007 175.932.505 79.11%
2009 597.254.800 70.54%
2010 485.621.565 -22.99%
2011 311.452.000 -55.92%
2012 921.879.000 66.22%
2013 1.079.484.000 14.6%
2014 1.453.326.000 25.72%
2015 1.437.910.000 -1.07%
2016 1.934.257.000 25.66%
2017 -6.505.000 29834.93%
2018 2.622.441.000 100.25%
2019 4.761.884.000 44.93%
2020 4.324.778.000 -10.11%
2021 3.320.541.000 -30.24%
2022 6.636.780.000 49.97%
2023 0 0%
2023 3.395.180.000 100%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Granules India Limited Capital Expenditure
Year Capital Expenditure Growth
2006 -744.323.181
2007 -540.351.773 -37.75%
2009 127.898.379 522.49%
2010 249.626.265 48.76%
2011 577.794.000 56.8%
2012 1.164.461.000 50.38%
2013 2.667.334.000 56.34%
2014 1.480.841.000 -80.12%
2015 1.346.720.000 -9.96%
2016 3.097.173.000 56.52%
2017 4.464.365.000 30.62%
2018 2.794.034.000 -59.78%
2019 1.844.790.000 -51.46%
2020 2.713.416.000 32.01%
2021 3.977.069.000 31.77%
2022 2.117.930.000 -87.78%
2023 0 0%
2023 3.805.760.000 100%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Granules India Limited Equity
Year Equity Growth
2006 1.674.223.940
2007 1.736.283.511 3.57%
2008 1.749.415.903 0.75%
2009 2.023.803.191 13.56%
2010 2.197.795.182 7.92%
2011 2.450.893.000 10.33%
2012 2.748.513.000 10.83%
2013 3.559.621.000 22.79%
2014 4.311.635.000 17.44%
2015 6.660.387.000 35.26%
2016 9.035.954.000 26.29%
2017 13.041.759.000 30.72%
2018 15.294.731.000 14.73%
2019 18.437.241.000 17.04%
2020 21.732.743.000 15.16%
2021 25.870.904.000 16%
2022 28.349.090.000 8.74%
2023 32.255.440.000 12.11%
2023 29.674.140.000 -8.7%
2024 32.255.440.000 8%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Granules India Limited Assets
Year Assets Growth
2006 3.302.177.244
2007 3.720.196.393 11.24%
2008 4.047.682.972 8.09%
2009 4.119.681.651 1.75%
2010 4.348.672.808 5.27%
2011 5.713.146.000 23.88%
2012 6.827.370.000 16.32%
2013 9.920.134.000 31.18%
2014 11.971.384.000 17.13%
2015 14.528.710.000 17.6%
2016 18.764.254.000 22.57%
2017 26.438.898.000 29.03%
2018 29.828.132.000 11.36%
2019 33.014.996.000 9.65%
2020 37.134.504.000 11.09%
2021 45.128.976.000 17.71%
2022 49.045.640.000 7.99%
2023 55.209.820.000 11.17%
2023 52.648.490.000 -4.86%
2024 0 0%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Granules India Limited Liabilities
Year Liabilities Growth
2006 1.627.953.304
2007 1.983.912.882 17.94%
2008 2.298.267.069 13.68%
2009 2.095.878.460 -9.66%
2010 2.150.877.626 2.56%
2011 3.262.253.000 34.07%
2012 4.078.857.000 20.02%
2013 6.360.513.000 35.87%
2014 7.659.749.000 16.96%
2015 7.868.323.000 2.65%
2016 9.728.300.000 19.12%
2017 13.397.139.000 27.39%
2018 14.533.401.000 7.82%
2019 14.577.755.000 0.3%
2020 15.401.761.000 5.35%
2021 19.258.072.000 20.02%
2022 20.696.550.000 6.95%
2023 22.954.380.000 9.84%
2023 22.974.350.000 0.09%
2024 0 0%

Granules India Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
193.95
Net Income per Share
20.3
Price to Earning Ratio
27.41x
Price To Sales Ratio
2.87x
POCF Ratio
64.28
PFCF Ratio
64.28
Price to Book Ratio
4.18
EV to Sales
2.95
EV Over EBITDA
14.14
EV to Operating CashFlow
66.1
EV to FreeCashFlow
66.1
Earnings Yield
0.04
FreeCashFlow Yield
0.02
Market Cap
134,88 Bil.
Enterprise Value
138,69 Bil.
Graham Number
246.56
Graham NetNet
15.72

Income Statement Metrics

Net Income per Share
20.3
Income Quality
0.43
ROE
0.16
Return On Assets
0
Return On Capital Employed
0
Net Income per EBT
0.74
EBT Per Ebit
0.86
Ebit per Revenue
0.16
Effective Tax Rate
0.26

Margins

Sales, General, & Administrative to Revenue
0.06
Research & Developement to Revenue
0.04
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.48
Operating Profit Margin
0.16
Pretax Profit Margin
0.14
Net Profit Margin
0.1

Dividends

Dividend Yield
0
Dividend Yield %
0.27
Payout Ratio
0
Dividend Per Share
1.5

Operating Metrics

Operating Cashflow per Share
8.66
Free CashFlow per Share
8.66
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.18
Return on Tangible Assets
0
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
15,72
Book Value per Share
0,00
Tangible Book Value per Share
0
Shareholders Equity per Share
133.08
Interest Debt per Share
4.55
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.39
Current Ratio
0
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
3,81 Bil.
Invested Capital
3811000000
Working Capital
3,81 Bil.
Intangibles to Total Assets
0
Average Receivables
4,93 Bil.
Average Payables
3,75 Bil.
Average Inventory
6502725000
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Granules India Limited Dividends
Year Dividends Growth
2005 1
2006 1 0%
2007 1 0%
2008 1 0%
2009 1 0%
2010 1 0%
2011 2 0%
2012 2 50%
2013 2 0%
2014 4 33.33%
2015 1 0%
2016 1 0%
2017 1 100%
2018 1 0%
2019 1 0%
2020 1 0%
2021 2 0%
2022 1 0%
2023 2 0%
2024 2 0%

Granules India Limited Profile

About Granules India Limited

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

CEO
Dr. Kandiraju Venkata Sita Ram
Employee
4.057
Address
My Home Hub
Hyderabad, 500081

Granules India Limited Executives & BODs

Granules India Limited Executives & BODs
# Name Age
1 Mr. Sanjay Kumar
President and Chief Strategy & Sustainability Officer
70
2 Mr. Mukesh Surana
Chief Financial Officer
70
3 Dr. Krishna Prasad Chigurupati B.Sc.
Chairman & MD
70
4 Mr. Harsha Chigurupati BBA
Executive Director
70
5 Ms. Chaitanya Tummala
Company Secretary & Compliance Officer
70
6 Ms. Priyanka Chigurupati
Whole-Time Director
70
7 Mr. Atul Dhavle B.E.
Chief Human Resources Officer
70
8 Dr. P. V. Srinivas
Chief Technology Officer
70
9 Dr. Kandiraju Venkata Sita Ram Rao B.Tech, M.E., Ph.D.
Joint MD, Chief Executive Officer & Additional Director
70
10 Mr. Sethu Madhavan Sankaran
Senior Vice President of API Manufacturing & Operations
70

Granules India Limited Competitors

Laurus Labs Limited Logo
Laurus Labs Limited

LAURUSLABS.NS

(2.2)
Aurobindo Pharma Limited Logo
Aurobindo Pharma Limited

AUROPHARMA.NS

(2.5)
Ipca Laboratories Limited Logo
Ipca Laboratories Limited

IPCALAB.NS

(2.8)